SEC FIlings

03 Feb

SEC FIlings

Statement of acquisition of beneficial ownership by individuals

November 17, 2022
Posted by Jitendra

02 Feb

SEC FIlings

Statement of acquisition of beneficial ownership by individuals – Amendment

November 17, 2022
Posted by Jitendra

10 Jan

SEC FIlings

Statement of acquisition of beneficial ownership by individuals

November 17, 2022
Posted by Jitendra

07 Jan

SEC FIlings

Current report

November 17, 2022
Posted by Jitendra

08 Dec

SEC FIlings

Quarterly report for quarter ending Sept 30, 2021 – Amendment

November 17, 2022
Posted by Jitendra

07 Dec

SEC FIlings

Current report

November 17, 2022
Posted by Jitendra

06 Dec

SEC FIlings

Current report

November 17, 2022
Posted by Jitendra

10 Nov

SEC FIlings

Quarterly report for quarter ending Sept 30, 2021

November 17, 2022
Posted by Jitendra

24 Aug

SEC FIlings

Quarterly report for quarter ending June 30, 2021 – Amendment

November 17, 2022
Posted by Jitendra

19 Aug

SEC FIlings

Quarterly report for quarter ending June 30, 2021

November 17, 2022
Posted by Jitendra

Statement of acquisition of beneficial ownership by individuals

Statement of acquisition of beneficial ownership by individuals – Amendment

Statement of acquisition of beneficial ownership by individuals

Current report

Quarterly report for quarter ending Sept 30, 2021 – Amendment

Current report

Current report

Quarterly report for quarter ending Sept 30, 2021

Quarterly report for quarter ending June 30, 2021 – Amendment

Quarterly report for quarter ending June 30, 2021

Gloperba Launch – Nasdaq-2024

A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain

Gout Awareness Day – May 22

Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis

Retrospective Claims Analysis of Decreased Healthcare Visits with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch